Neonatal Outcomes of Pregnant Women With Confirmed Coronavirus Disease 2019: One-Year Experience of a Tertiary Care Center
Citation
Melekoglu, N. A., Ozdemir, H., & Yasar, S. (2021). Neonatal Outcomes of Pregnant Women With Confirmed Coronavirus Disease 2019: One-Year Experience of a Tertiary Care Center. Clinical pediatrics, 00099228211059886.Abstract
The coronavirus disease 2019 (COVID-19) pandemic became an important public health problem affecting all age
groups. The aim of this study was to evaluate clinical and laboratory findings of newborns born to mothers with
COVID-19. Thirty pregnant women with COVID-19 were admitted to Turgut Ozal University Hospital for delivery.
Fourteen pregnant women had at least one symptom associated with COVID-19. Positive polymerase chain reaction
(PCR) results were seen in only 3 (9.7%) of 31 newborns. A statistically significant difference was observed between
PCR-positive and PCR-negative newborns in terms of any adverse pregnancy outcomes. Neonatal lymphocyte
count and partial arterial oxygen pressure were significantly lower in the PCR-positive group. Results were also
compared according to the interval from the maternal diagnosis time to delivery. Hemoglobin and hematocrit levels
in newborns born to mothers diagnosed more than 7 days before delivery were significantly lower. Neonates born
to mothers with COVID-19 had mild clinical symptoms and favorable outcomes